As
you may know, Medicare Part D prescription drug plans update their plan formularies (drug lists) throughout the plan
year and the March 2019
Medicare Part D formulary updates included 198 new drugs, 53 of which are new generic drugs - with a total of 72 new generic equivalents
(variations of manufacturer, drug-strength, and packaging).
Below is a full list of the new generics added to the 2019 Medicare Part D (PDP) and Medicare Advantage plan (MAPD) formularies:
|
|
Number of |
Number of |
| ABIRATERONE ACETATE 250 MG TABLET [ZYTIGA] | 55 | 284 |
| ADAPALENE 0.1% SOLUTION [Plixda] | 2 | 39 |
| ALENDRONATE SODIUM 35 MG TABLET [Fosamax] | 62 | 353 |
| ALENDRONATE SODIUM 70 MG TABLET [Fosamax] | 62 | 353 |
| AMLODIPINE BESYLATE 10 MG TABLET [Norvasc] | 62 | 353 |
| AMLODIPINE BESYLATE 5 MG TABLET [Norvasc] | 62 | 353 |
| AMLODIPINE-BENAZEPRIL 10-40 MG Capsule [Lotrel] | 53 | 347 |
| AMLODIPINE-BENAZEPRIL 5-40 MG Capsule [Lotrel] | 53 | 347 |
| AMPHETAMINE SULFATE 10 MG TABLET [Evekeo] | 1 | 18 |
| AMPHETAMINE SULFATE 5 MG TABLET [Evekeo] | 1 | 18 |
| AZELAIC ACID 15% GEL [Finacea] | 26 | 188 |
| BUPROPION HCL XL 450 MG TABLET ER 24H [Forfivo XL] | 3 | 100 |
| CEFEPIME HCL 1 GM VIAL [Maxipime] | 62 | 353 |
| CEFEPIME HCL 2 GRAM VIAL [Maxipime] | 60 | 351 |
| CLIND PH-BENZOYL PERO 1.2-2.5% GEL W/PUMP [Acanya] | 10 | 49 |
| CLOBAZAM 10 MG TABLET [ONFI] | 62 | 353 |
| CLOBAZAM 2.5 MG/ML Oral Suspension [ONFI] | 62 | 353 |
| CLOBAZAM 20 MG TABLET [ONFI] | 62 | 353 |
| COLESEVELAM HCL 3.75 G PACKET POWD PACK [WelChol] | 31 | 242 |
| CYRED EQ 28 DAY TABLET [Solia] | 49 | 287 |
| DALFAMPRIDINE ER 10 MG TABLET ER 12H [Ampyra] | 58 | 341 |
| DAPTOMYCIN 350 MG VIAL [Cubicin RF] | 42 | 288 |
| DESOXIMETASONE 0.25% SPRAY [Topicort] | 6 | 50 |
| DEXAMETHASONE 10 DAY 1.5 MG TABLET DS PK [ZonaCort 7 Day] | 8 | 89 |
| DEXAMETHASONE 13 DAY 1.5 MG TABLET DS PK [ZonaCort 7 Day] | 8 | 91 |
| DEXAMETHASONE 6 DAY 1.5 MG TABLET DS PK [ZonaCort 7 Day] | 8 | 88 |
| DORZOLAMIDE-TIMOLOL 2%-0.5% DROPERETTE [Cosopt PF] | 14 | 113 |
| DROSP-EE-LEVOMEF 3-0.02-0.451 TABLET [Beyaz] | 24 | 146 |
| ERTAPENEM 1 GRAM VIAL [Invanz] | 48 | 337 |
| FLAC OTIC OIL 0.01% EAR DROPS [Flac] | 41 | 185 |
| HYDROCORTISONE BUTYR 0.1% LOTION [Locoid] | 7 | 81 |
| HYDROMORPHONE HCL ER 12 MG TABLET ER 24H [Exalgo] | 4 | 76 |
| HYDROMORPHONE HCL ER 16 MG TABLET ER 24H [Exalgo] | 5 | 78 |
| HYDROMORPHONE HCL ER 8 MG TABLET ER 24H [Exalgo] | 4 | 76 |
| IMIQUIMOD 3.75% CREAM PUMP CRM MD PMP [Zyclara] | 6 | 105 |
| ITRACONAZOLE 10 MG/ML SOLUTION [Sporanox] | 20 | 128 |
| KETOPROFEN 25 MG CAPSULE [Orudis] | 23 | 173 |
| KETOROLAC 0.4% OPHTH SOLUTION Drops [Acular LS] | 62 | 352 |
| LACTULOSE 10 GM PACKET [Kristalose] | 7 | 63 |
| LEDIPASVIR-SOFOSBUVIR 90-400MG TABLET [Harvoni] | 8 | 103 |
| LEVOFLOXACIN 500 MG/20 ML VIAL [Levaquin] | 59 | 343 |
| LIOTHYRONINE SOD 50 MCG TABLET [Cytomel] | 62 | 353 |
| MESALAMINE 800 MG DR TABLET DR [Asacol HD] | 36 | 258 |
| MINOCYCLINE ER 55 MG TABLET ER 24H [Solodyn] | 2 | 24 |
| MONDOXYNE NL 100 MG CAPSULE [Monodox] | 42 | 228 |
| MONDOXYNE NL 75 MG CAPSULE [NutriDox] | 25 | 100 |
| MORPHINE SULF 10 MG/5 ML Solution [MSIR] | 56 | 333 |
| MORPHINE SULF 20 MG/5 ML Solution [MSIR] | 56 | 334 |
| MORPHINE SULFATE ER 40 MG CAP ER PEL [Kadian] | 6 | 89 |
| NITROFURANTOIN MCR 100 MG CAPSULE [Macrodantin] | 62 | 349 |
| OXYCODONE-ACETAMINOPHEN 10-325 TABLET [Percocet] | 62 | 353 |
| PIOGLITAZONE-GLIMEPIRIDE 30-2 TABLET [Duetact] | 20 | 191 |
| PIPERACIL-TAZOBACT 40.5 GRAM VIAL [Zosyn] | 48 | 307 |
| POTASSIUM CL 10% (20 MEQ/15ML) Liquid [Kay Ciel] | 62 | 353 |
| POTASSIUM CL 20% (40 MEQ/15ML) Liquid [Kaon-CL] | 48 | 315 |
| PRIMIDONE 250 MG TABLET [Mysoline] | 62 | 353 |
| PRIMIDONE 50 MG TABLET [Mysoline] | 62 | 353 |
| PROMETHAZINE-PHENYLEPHRINE SYRUP [Prometh VC Plain] | 2 | 136 |
| PRUDOXIN 5% CREAM (g) [Zonalon] | 10 | 40 |
| QUININE SULFATE 324 MG CAPSULE [Qualaquin] | 44 | 295 |
| SOFOSBUVIR-VELPATASVIR 400-100 TABLET [Epclusa] | 8 | 158 |
| SOTALOL 120 MG TABLET [Sorine] | 62 | 345 |
| TADALAFIL 2.5 MG TABLET [Cialis] | 3 | 61 |
| TADALAFIL 5 MG TABLET [Cialis] | 3 | 62 |
| TELMISARTAN 20 MG TABLET [Micardis] | 51 | 314 |
| TENOFOVIR DISOP FUM 300 MG TABLET [Viread] | 62 | 352 |
| TESTOSTERONE 1.62% (1.25 G) PKT GEL PACKET [AndroGel] | 37 | 241 |
| TESTOSTERONE 1.62% (2.5 G) PKT GEL PACKET [AndroGel] | 37 | 245 |
| TESTOSTERONE 1.62% GEL PUMP GEL MD PMP [AndroGel] | 37 | 240 |
| TRANYLCYPROMINE SULF 10 MG TABLET [Parnate] | 62 | 353 |
| TRETINOIN 0.05% GEL [Atralin] | 19 | 191 |
| VORICONAZOLE 200 MG TABLET [VFEND] | 62 | 353 |
- You may be able to save money by switching
from the brand-name drug to its generic equivalent – with your prescriber’s
approval and a new prescription. Please note, you will need to look
carefully at coverage costs as we have found that many 2019 generics are being
offered on the same tier as their brand-name equivalent or the generics do not
have a significantly lower retail price.
- Your brand-name drug may no longer be available if a generic is now available. Based on past experience, you may find that many Medicare Part D plans discontinue coverage for the brand-name drug in the months following the introduction of the generic equivalent. If you have received notice from your Medicare Part D plan that your brand-name medication will be dropped, you should speak with your prescriber to determine if you can take the generic equivalent or if you must continue taking the brand-name drug, you will need to ask your plan for a formulary exception to continue coverage for your brand-name drug. You can click for a chart showing the trends in formulary coverage for some of the more popular Medicare drugs and their generic equivalents.